OXFORD BIODYNAMICS LS-01
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more
OXFORD BIODYNAMICS LS-01 (LMQ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, OXFORD BIODYNAMICS LS-01 (LMQ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
OXFORD BIODYNAMICS LS-01 - Net Assets Trend (None–None)
This chart illustrates how OXFORD BIODYNAMICS LS-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OXFORD BIODYNAMICS LS-01 (None–None)
The table below shows the annual net assets of OXFORD BIODYNAMICS LS-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to OXFORD BIODYNAMICS LS-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
OXFORD BIODYNAMICS LS-01 Competitors by Market Cap
The table below lists competitors of OXFORD BIODYNAMICS LS-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bioter S.A.
AT:BIOT
|
$1.57 Million |
|
Telkonet Inc
PINK:TKOI
|
$1.57 Million |
|
Danish Aerospace Company A/S
CO:DAC
|
$1.57 Million |
|
Idaho Copper Corporation
OTCMKTS:COPR
|
$1.57 Million |
|
NICE CALL PUBLIC COMPANY LIMITED
BK:NCP
|
$1.57 Million |
|
ALUMINIUM DU MAROC
BC:ALUMINIUM-DU-MAROC
|
$1.57 Million |
|
MARKETAXESS HOLDING
MU:MWI
|
$1.57 Million |
|
Instituto Rosenbusch S.A.
BA:ROSE
|
$1.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OXFORD BIODYNAMICS LS-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares OXFORD BIODYNAMICS LS-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently OXFORD BIODYNAMICS LS-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares OXFORD BIODYNAMICS LS-01's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OXFORD BIODYNAMICS LS-01 (LMQ) | €- | N/A | N/A | $1.57 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |